Science & Enterprise subscription

Follow us on Twitter

  • A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple… https://t.co/0PktfkzyNH
    about 1 hour ago
  • New post on Science and Enterprise: FDA Halts Off-the-Shelf Engineered T-Cell Trial https://t.co/Fbz7IKCgky #Science #Business
    about 1 hour ago
  • If you dig deep into the Science & Enterprise archives, you'll find this site began posting on 6 July 2010, exactly… https://t.co/eGPudMExsK
    about 18 hours ago
  • New post on Science and Enterprise: Essay – Ten Years and Counting https://t.co/bIFz5ld4g4 #Science #Business
    about 18 hours ago
  • A cocktail of two synthetic antibodies will soon be tested in a clinical trial to prevent against Covid-19 infectio… https://t.co/auyvJKhyBq
    about 20 hours ago

Please share Science & Enterprise

Advertise on Science & Enterprise

 

Tablet, laptop

(Pixnio)

Science & Enterprise attracts a unique combination of business, academic, scientific, and technological readers looking for serious news on matters with direct consequences for their companies, organizations, or individual careers. To reach these readers, Science & Enterprise offers guest posts as native advertising opportunities.

Guest posts run about 500 words, and relate to the broad themes of science, technology, and business. You only need to provide text with links, subject to our review. We can provide a suitable image to go with the text, if you wish.

Please note that we label guest posts as sponsored content and do not accept any attributes on links, such as do-follow, that violate Google’s guidelines. And we do not accept any content related to gambling, gaming, fantasy sports, smoking, firearms, pornography, sexually-oriented businesses, or predatory loans.

The latest media kit for Science & Enterprise describing our editorial objectives and advertising opportunities is now available for download. For more information and current rates, please contact sciencebusiness [at] technewslit [dot] com.

*     *     *